United States · FDA National Drug Code directory

Carbidopa and Levodopa

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 46708-333_a85a56c5-44dd-41d4-ac1c-bdc4758406a4
Product NDC: 46708-333
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Carbidopa and Levodopa
Labeler: Alembic Pharmaceuticals Limited
Marketing category: ANDA
Marketing start / end (source format): 20190606
Source listing expiry: 20261231

Source-listed ingredients

CARBIDOPA — 50 mg/1
LEVODOPA — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-30) · 46708-333-30
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-31) · 46708-333-31
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-333-91) · 46708-333-91

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →